Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

Eli Lilly and Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

Lilly drops Zepbound single-dose vial prices on LillyDirect, offering lower costs and more access options for patients with a valid prescription.

Eli Lilly has cut cash prices for its weight-loss drug Zepbound on LillyDirect, lowering monthly costs to $299–$449. The move ...

The FTSE 100 index closed down 17.98 points, 0.2%, at 9,702.53. The FTSE 250 ended down 144.49 points, 0.7%, at 22,020.68, ...

The Vitamin Shoppe®, an omni-channel specialty retailer of nutritional products, today announced two executive appointments that further strengthen its leadership team and support the company's new ...

The FTSE 100 index closed down 17.98 points, 0.2%, at 9,702.53. The FTSE 250 ended down 144.49 points, 0.7%, at 22,020.68, and the AIM All-Share closed up 0.71 points, 0.1%, at 754.79.

A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a ...

Eli Lilly is cutting prices again for those who pay cash for introductory doses of the weight-loss drug Zepbound. The lowest ...